Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 3.40 INR
Change Today 0.00 / 0.00%
Volume 0.0
VKTP On Other Exchanges
Symbol
Exchange
Mumbai
As of 7:40 AM 06/8/15 All times are local (Market data is delayed by at least 15 minutes).

venkat pharma ltd (VKTP) Snapshot

Open
--
Previous Close
3.40
Day High
--
Day Low
--
52 Week High
10/13/14 - 3.78
52 Week Low
11/14/14 - 2.34
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
-0.03
Shares Outstanding
5.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VENKAT PHARMA LTD (VKTP)

Related News

No related news articles were found.

venkat pharma ltd (VKTP) Related Businessweek News

No Related Businessweek News Found

venkat pharma ltd (VKTP) Details

Venkat Pharma Limited does not have significant operations. Previously, the company was engaged in the manufacture and sale of finished dosages of pharmaceutical products in India. Venkat Pharma Limited was incorporated in 1989 and is based in Hyderabad, India.

Founded in 1989

venkat pharma ltd (VKTP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

venkat pharma ltd (VKTP) Key Developments

Venkat Pharma Ltd Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Venkat Pharma Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported loss from operations before other income, interest and exceptional items of INR 0.092 million against INR 0.104 a year ago. Loss from ordinary activities before tax was INR 0.092 million against INR 0.104 million a year ago. Net loss for the period was INR 0.092 million against INR 0.104 million a year ago. For the six months, the company reported loss from operations before other income, interest and exceptional items of INR 0.236 million against INR 0.144 a year ago. Loss from ordinary activities before tax was INR 0.236 million against INR 0.144 million a year ago. Net loss for the period was INR 0.236 million against INR 0.144 million a year ago.

Venkat Pharma Ltd, Board Meeting, Nov 14, 2014

Venkat Pharma Ltd, Board Meeting, Nov 14, 2014. Agenda: To consider unaudited standalone earnings results for the second quarter and six months ended September 30, 2014.

Venkat Pharma Ltd, Board Meeting, Aug 08, 2014

Venkat Pharma Ltd, Board Meeting, Aug 08, 2014. Agenda: To approve the unaudited standalone earnings results for the quarter ended June 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VKTP:IN 3.40 INR 0.00

VKTP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VKTP.
View Industry Companies
 

Industry Analysis

VKTP

Industry Average

Valuation VKTP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VENKAT PHARMA LTD, please visit www.venkatpharmaltd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.